person

Elena C. B.

Country
Spain
Department
Cardiologia

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 1 partner site.

Specializations

Acute Coronary Syndromes & Myocardial Infarction

The investigator concentrates on rapid management and secondary prevention for patients experiencing Acute myocardial infarction and related coronary events.

  • Percutaneous coronary intervention
  • Secondary prevention with lipid‑lowering therapy
  • ST‑segment elevation myocardial infarction

Efforts aim to lower recurrent ischemic episodes and improve long‑term survival.

Chronic Heart Failure

Research targets therapeutic strategies for both Heart Failure with Reduced Ejection Fraction and Heart Failure with Preserved Ejection Fraction.

  • Biomarker‑guided treatment
  • Optimisation of guideline‑directed medical therapy
  • Management of comorbid renal dysfunction

The goal is to enhance functional capacity and reduce hospitalisation rates.

Cardiac Amyloidosis

Focus is placed on protein‑misfolding cardiomyopathies, including Transthyretin amyloid cardiomyopathy and AL cardiac amyloidosis.

  • Disease‑modifying agents
  • Advanced cardiac imaging for amyloid burden
  • Functional outcome assessments

Investigations seek to halt disease progression and improve quality of life.

Arrhythmias & Thromboembolic Risk

Studies address rhythm disorders such as Atrial fibrillation and complications like Left atrial appendage closure device thrombosis.

  • Anticoagulation reversal strategies
  • Risk stratification for stroke
  • Device‑related thrombotic monitoring

Balancing efficacy of stroke prevention with bleeding safety is a central aim.

Lipid Disorders & Atherosclerotic Disease

Research explores elevated lipoprotein markers and inherited dyslipidaemias contributing to Atherosclerotic cardiovascular disease.

  • Elevated lipoprotein(a)
  • Homozygous familial hypercholesterolemia
  • Novel lipid‑modifying therapies

Efforts aim to achieve aggressive risk reduction in high‑risk populations.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.